The drug regulatory process in Finland.
作者信息
Pirjola J, Holttinen K
机构信息
Huhtamäki Oy Leiras, Turku, Finland.
出版信息
J Clin Pharmacol. 1989 Apr;29(4):293-9. doi: 10.1002/j.1552-4604.1989.tb03330.x.
Abstract
摘要
相似文献
1
The drug regulatory process in Finland.
J Clin Pharmacol. 1989 Apr;29(4):293-9. doi: 10.1002/j.1552-4604.1989.tb03330.x.
2
The drug regulatory affairs system in the Federal Republic of Germany.
J Clin Pharmacol. 1988 Dec;28(12):1064-70. doi: 10.1002/j.1552-4604.1988.tb05715.x.
3
Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
J Pharm Pharm Sci. 1998 Jan-Apr;1(1):2-7.
4
Medicines registration review process in Mexico.
J Clin Pharmacol. 1988 Jul;28(7):577-83. doi: 10.1002/j.1552-4604.1988.tb03180.x.
5
QUAD routes out inferior drugs.
Can Hosp. 1973 May;50(5):58-9.
6
[The new norms decreed by the legislative dirrective 91-93 CCE].
Boll Chim Farm. 1998 Feb;137(2):31-4.
7
Analysis of safety-related regulatory actions by Japan's pharmaceutical regulatory agency.
Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1314-1320. doi: 10.1002/pds.4252. Epub 2017 Jul 19.
8
Present attitudes of governmental drug regulatory agencies.
Int J Clin Pharmacol. 1973 Apr;7(2):168-77.
9
Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
Fed Regist. 1978 Sep 29;43(190 Pt 2):45013-89.
10
The community pharmacist: health sentinel on the home front.
Am J Public Health. 1974 Aug;64(8):811-2. doi: 10.2105/ajph.64.8.811.
Zotero 插件